Merck Healthcare / M Ventures’ W Accelerate Innovation programme
It really matters who is in the room you’re in. Two years ago Lara and I pitched at the inaugural Merck Healthcare / M Ventures W Accelerate Innovation programme run by W Group The event was fantastic. The seniority of the people in that room were impressive, and the conversations that started there became the …
University of Oxford SASHI 2026
Day Two of the Oxford Summer Academy for the Social Science of Health Innovation (SASHI)– The Women’s Health Revolution: Women’s and Reproductive Health Equity –held at St Hilda’s College, University of Oxford 🏛️ Great to return to Oxford for a fireside chat with Dr Emma Thornton. I talked about exciting progress on our progesterone-Callavid® clinical …
Chair of the WHH summit in Washington D.C.
Super excited to chair the Women’s Health Horizons DC summit on October 7 and be a panelist on “Medical Education as Health Policy: If We Don’t Teach It, We Don’t Treat It.” Everything policy and women’s health. It’s a real milestone in my life. The realization that everyone would prefer it if what I have …
Callavid feature in Technology Networks
We’re delighted to be featured by Technology Networks in this interview with our co-founders, Dr Lara Zibners and Thang Vo-Ta, about our Callavid® intravaginal drug delivery platform. Our first focus is progesterone delivery for threatened miscarriage and IVF– areas where the clinical need is significant, but where the patient experience has too often been overlooked. …
World Clinical Trials Day
It was recently World Clinical Trials Day, and our co-founder Lara took part in a special event hosted by SökerData and Covington & Burling LLP: 🔬 “Innovation in Action: Successful Women’s Clinical Trial Case Studies” 🧪 Lara shared the context, design and exciting early progress of our ongoing FREEDOM clinical trial evaluating Callavid® for threatened …
Returning to Barclays HQ for Demo Day
About 18 months after taking part in the inaugural Barclays Demo Day, it was great to return to Barclays’ Canary Wharf HQ to present Calla Lily Clinical Care again. Last time, we were pitching our ambitious plans to transform drug delivery for women. This time, those plans are bolder than ever– but now backed by …
At the Cleveland Clinic Global Women’s Health + WAM Forum
CLCC was delighted to have taken part in the Cleveland Clinic Global Women’s Health Forum, co-hosted by the Women’s Alzheimer’s Movement and Maria Shriver. It was an inspiring gathering of voices across medicine, research, advocacy, and innovation, with important conversations spanning heart and brain health, strength, mental wellbeing, financial health, and more. 💪 Our co-founder …
Forbes features CLCC
Original article here by Geri Stengel Picture the pitch room. Dr. Lara Zibners has a question for the male-majority audience. “How many of you have put medication up your nose?” A few hands go up. Then: “…besides cocaine.” Laughter. Then the turn: if nasal drugs leaked the way vaginal drugs do, one of them …
Drug Dev & Delivery: How Vaginal Therapeutics Are Finally Getting the Platform They Deserve
original article here: https://drug-dev.com/expert-content/the-most-underutilized-route-in-drug-delivery-how-vaginal-therapeutics-are-finally-getting-the-platform-they-deserve/ The Most Underutilized Route in Drug Delivery: How Vaginal Therapeutics Are Finally Getting the Platform They Deserve By: Lara Zibners, MD, MMEd, MBA Women are: 51% of the population The majority of prescription drug users (QuickStats, MMWR, 2023) Almost always the medical decision maker for the family (US Dept of Labor) And, …
At the HERS Summit in San Diego, CA
Inspired by two packed days at the inaugural HERS summit in sunny San Diego ☀️ with such clear momentum across women’s health. But what was particularly energising and impressive was seeing several scientific breakthroughs and growing successes emerging across the space. None of which have been easy. They’ve all been very hard fought, against the …